<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2985087R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4945</journal-id>
<journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Med. Genet.</journal-id>
<journal-title-group>
<journal-title>Journal of medical genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-2593</issn>
<issn pub-type="epub">1468-6244</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26673778</article-id>
<article-id pub-id-type="pmc">5057575</article-id>
<article-id pub-id-type="doi">10.1136/jmedgenet-2015-103304</article-id>
<article-id pub-id-type="manuscript">NIHMS821207</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Large-scale targeted sequencing comparison highlights extreme genetic heterogeneity in nephronophthisis-related ciliopathies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Schueler</surname>
<given-names>Markus</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Halbritter</surname>
<given-names>Jan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Phelps</surname>
<given-names>Ian G.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Braun</surname>
<given-names>Daniela A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Otto</surname>
<given-names>Edgar A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Porath</surname>
<given-names>Jonathan D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gee</surname>
<given-names>Heon Yung</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shendure</surname>
<given-names>Jay</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Roak</surname>
<given-names>Brian J.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lawson</surname>
<given-names>Jennifer A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soliman</surname>
<given-names>Neveen A.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nabhan</surname>
<given-names>Marwa M.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Doherty</surname>
<given-names>Dan</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hildebrandt</surname>
<given-names>Friedhelm</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Divison of Nephology, Department of Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA</aff>
<aff id="A2"><label>2</label>Divison of Nephrology, Department of Internal Medicine, University Clinic Leipzig, Leipzig, Germany</aff>
<aff id="A3"><label>3</label>Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA</aff>
<aff id="A4"><label>4</label>Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA</aff>
<aff id="A5"><label>5</label>University of Washington, Genome Sciences, Seattle, WA, USA</aff>
<aff id="A6"><label>6</label>Oregon Health and Science University, Molecular and Medical Genetics, Portland, OR, USA</aff>
<aff id="A7"><label>7</label>Center of Pediatric Nephrology &amp; Transplantation, Cairo University, Cairo, Egypt</aff>
<aff id="A8"><label>8</label>Egyptian Group for Orphan Renal Diseases (EGORD), Cairo, Egypt</aff>
<aff id="A9"><label>9</label>Howard Hughes Medical Institute, Chevy Chase, MD, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence should be addressed to: Friedhelm Hildebrandt, M.D., Division of Nephrology, Boston Children’s Hospital, 300 Longwood Avenue, Boston, Massachusetts 02115, Phone: +1 617-355-6129, Fax: +1 617-730-0365, <email>friedhelm.hildebrandt@childrens.harvard.edu</email>. Dan Doherty, MD, PhD, Associate Professor of Pediatrics, Divisions of Developmental Medicine and Genetic Medicine, University of Washington, Seattle Children’s Hospital, Seattle, WA 98195, USA, <email>ddoher@uw.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<label>*</label>
<p>These authors contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>53</volume>
<issue>3</issue>
<fpage>208</fpage>
<lpage>214</lpage>
<!--elocation-id from pubmed: 10.1136/jmedgenet-2015-103304-->
<abstract>
<p id="P1">The term nephronophthisis-related ciliopathies (NPHP-RC) describes a group of rare autosomal-recessive cystic kidney diseases, characterized by broad genetic and clinical heterogeneity. NPHP-RC is frequently associated with extrarenal manifestations and accounts for the majority of genetically caused chronic kidney disease (CKD) during childhood and adolescence. Generation of a molecular diagnosis has been impaired by this broad genetic heterogeneity. However, recently developed high-throughput exon sequencing techniques represent powerful and efficient tools to screen large cohorts for dozens of causative genes. Therefore, we performed massively multiplexed targeted sequencing using the modified molecular inversion probe (MIPs) strategy in an international cohort of 384 patients diagnosed with NPHP-RC. As a result, we established the molecular diagnoses in 81/384 unrelated individuals (21.1%). We detected 127 likely disease-causing mutations in 18 of 34 evaluated NPHP-RC genes, 22 of which were novel. We further compared a subgroup of current findings to the results of a previous study in which we used an array-based microfluidic PCR technology in the same cohort. While 78 likely disease-causing mutations were previously detected by the array-based microfluidic PCR, the MIPs approach identified 94 likely pathogenic mutations. Compared to the previous approach, MIPs re-detected 66 out of 78 variants and 28 previously unidentified variants, for a total of 94 variants. In summary, we demonstrate that the modified MIPs technology is a useful approach to screen large cohorts for a multitude of established NPHP genes in order to identify the underlying molecular cause. Combined application of two independent library preparation and sequencing techniques, however, may still be indicated for Mendelian diseases with extensive genetic heterogeneity in order to further increase diagnostic sensitivity.</p>
</abstract>
<kwd-group>
<kwd>NPHP</kwd>
<kwd>ciliopathies</kwd>
<kwd>MIP</kwd>
<kwd>cystic kidney disease</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>